Poseida Therapeutics, Inc. (PSTX) Tops Q3 EPS by 63c
Tweet
Share
E-mailGet Alerts PSTX Hot Sheet
Price: $9.50 --0%
Financial Fact:
Net (loss) income applicable to common shareholders: -526.96K
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Net (loss) income applicable to common shareholders: -526.96K
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Poseida Therapeutics, Inc. (NASDAQ: PSTX) reported Q3 EPS of $0.21, $0.63 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $71.75 million versus the consensus estimate of $16.25 million.
For earnings history and earnings-related data on Poseida Therapeutics, Inc. (PSTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Raytheon wins $42.5 million in Navy F/A-18 spare parts deals
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
